A Study of Concurrent Chemoradiotherapy Based of Cisplatin With or Without Sintilimab as First-line Therapy for Patients With Advanced Oral Cavity Squamous Cell Carcinoma

Category Primary study
Registry of TrialsClinicalTrials.gov
Year 2023
This study aims to evaluate the efficacy and safety of concurrent chemoradiotherapy based of cisplatin with sintilimab as first-line therapy for patients with advanced oral cavity squamous cell carcinoma.
Epistemonikos ID: d3f6bbaaa9c60f47c34ec414b5f6b70f5d0e0910
First added on: Feb 19, 2024